Related Experiment Video
Updated: Mar 24, 2026

07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
8.6K
Giant Benign Prostatic Hyperplasia in a Pakistani Patient
Zafaruddin Khan1, Muzamil Tahir1, H Shahzad Ashraf1
1Department of Urology and Transplantation, Shaikh Zayed Hospital, Lahore, Pakistan.
Urology Case Reports
|March 9, 2016
Summary
Giant prostate hyperplasia, a rare condition, was successfully treated with surgery in Pakistan. The removed prostate weighed 700g, making it one of the largest reported benign prostatic hyperplasia cases.
Area of Science:
- Urology
- Pathology
- Surgical Oncology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Giant prostatic hyperplasia is an extremely rare variant of BPH.
Observation:
- A case of giant prostatic hyperplasia was identified in an elderly male patient in Pakistan.
- The patient presented with symptoms necessitating surgical intervention.
Findings:
- A successful retropubic prostatectomy was performed.
- The resected prostate weighed 700g, representing one of the largest documented cases of BPH globally.
Implications:
- This case highlights the importance of considering rare pathologies even in familiar conditions.
- Successful surgical outcomes are achievable for even massive prostatic enlargement.
- Further research into the etiology and management of giant prostatic hyperplasia is warranted.
More Related Videos
Related Concept Videos
Disorders of the Male Reproductive System
5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
710
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
710

